INSP Stock Forecast 2025-2026
Distance to INSP Price Targets
INSP Price Momentum
🤔 Considering Inspire (INSP)?
Join 5,000+ investors getting our exclusive market analysis every Monday & Thursday. Stay ahead of breakout opportunities.
Latest INSP Stock Price Targets & Analyst Predictions
Based on our analysis of 17 Wall Street analysts, INSP has a bullish consensus with a median price target of $234.00 (ranging from $190.00 to $270.00). The overall analyst rating is Strong Buy (8.4/10). Currently trading at $162.16, the median forecast implies a 44.3% upside. This outlook is supported by 12 Buy, 5 Hold, and 0 Sell ratings.
Conversely, the most conservative target is provided by Jonathan Block at Stifel, suggesting a 17.2% upside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
INSP Analyst Ratings
INSP Price Target Range
Latest INSP Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for INSP.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Feb 11, 2025 | RBC Capital | Shagun Singh | Outperform | Reiterates | $260.00 |
| Feb 11, 2025 | Baird | Mike Polark | Outperform | Maintains | $248.00 |
| Feb 11, 2025 | Wells Fargo | Larry Biegelsen | Equal-Weight | Maintains | $195.00 |
| Feb 11, 2025 | Truist Securities | Richard Newitter | Buy | Maintains | $235.00 |
| Feb 11, 2025 | Morgan Stanley | Kallum Titchmarsh | Overweight | Maintains | $220.00 |
| Feb 10, 2025 | Piper Sandler | Adam Maeder | Overweight | Maintains | $233.00 |
| Jan 24, 2025 | Keybanc | Brett Fishbin | Overweight | Reiterates | $234.00 |
| Jan 21, 2025 | Stifel | Jonathan Block | Hold | Maintains | $190.00 |
| Nov 20, 2024 | B of A Securities | Bob Hopkins | Buy | Upgrade | $255.00 |
| Nov 5, 2024 | Baird | Mike Polark | Outperform | Maintains | $252.00 |
| Nov 5, 2024 | Stifel | Jonathan Block | Hold | Reiterates | $200.00 |
| Nov 5, 2024 | RBC Capital | Shagun Singh | Outperform | Reiterates | $260.00 |
| Nov 5, 2024 | Piper Sandler | Adam Maeder | Overweight | Reiterates | $260.00 |
| Nov 5, 2024 | Wells Fargo | Larry Biegelsen | Equal-Weight | Maintains | $198.00 |
| Sep 30, 2024 | Truist Securities | Richard Newitter | Buy | Reiterates | $240.00 |
| Sep 10, 2024 | Leerink Partners | Mike Kratky | Market Perform | Maintains | $197.00 |
| Aug 7, 2024 | RBC Capital | Shagun Singh | Outperform | Reiterates | $260.00 |
| Aug 7, 2024 | Baird | Mike Polark | Outperform | Maintains | $200.00 |
| Aug 7, 2024 | Keybanc | Brett Fishbin | Overweight | Maintains | $236.00 |
| Jul 16, 2024 | Truist Securities | Richard Newitter | Buy | Maintains | $217.00 |
Inspire Medical Systems, Inc. (INSP) Competitors
The following stocks are similar to Inspire based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Inspire Medical Systems, Inc. (INSP) Financial Data
Inspire Medical Systems, Inc. has a market capitalization of $4.83B with a P/E ratio of 93.1x. The company generates $802.80M in trailing twelve-month revenue with a 6.7% profit margin.
Revenue growth is +24.5% quarter-over-quarter, while maintaining an operating margin of +13.3% and return on equity of +8.5%.
Valuation Metrics
Growth & Margins
Financial Health
🔥 Want More High-Potential Stock Ideas?
Join 5,000+ investors getting our research on stocks with massive upside potential.
Inspire Medical Systems, Inc. (INSP) Business Model
About Inspire Medical Systems, Inc.
Develops innovative technology for sleep apnea treatment.
Inspire Medical Systems generates revenue by developing and commercializing its Inspire therapy device, an implantable neurostimulation solution for obstructive sleep apnea patients who cannot use CPAP machines. The company collaborates with hospitals and medical professionals to integrate its technology into sleep health management, which helps expand its market reach.
Headquartered in Minnesota, the company is focused on providing less invasive and patient-friendly alternatives to traditional surgical treatments for sleep apnea. Inspire Medical Systems is part of a growing trend in healthcare that emphasizes personalized and technologically advanced solutions.
Company Information
Sector
Healthcare
Industry
Medical Devices
Employees
1,246
CEO
Mr. Timothy P. Herbert
Country
United States
IPO Year
2015
Website
www.inspiresleep.comInspire Medical Systems, Inc. (INSP) Latest News & Analysis
Inspire Medical Systems, Inc. to Present at the KeyBanc Capital Markets Healthcare Forum
10 days agoInspire Medical Systems (NYSE: INSP) will present at the KeyBanc Capital Markets Healthcare Forum on March 18, 2025, focusing on its solutions for obstructive sleep apnea.
Inspire Medical Systems' participation in the KeyBanc Capital Markets Healthcare Forum signals potential investor interest and could impact stock performance through increased visibility and investor engagement.
Zacks Premium offers the Zacks Style Scores, a tool that helps investors identify strong stocks across value, growth, and momentum categories.
The Zacks Style Scores enhance stock selection for various investment strategies, potentially improving portfolio performance and attracting more investors to the Zacks Premium service.
Kaskela Law LLC is investigating Inspire Medical Systems, Inc. (NYSE: INSP) on behalf of long-term shareholders as of February 17, 2025.
The investigation into Inspire Medical Systems may indicate potential legal issues or governance concerns, which could impact stock performance and shareholder value.
Inspire Medical reported strong revenue growth in both geographic segments due to solid product demand in Q4.
Strong revenue growth in both geographic segments indicates robust product demand, suggesting potential for increased profitability and investor confidence in Inspire Medical's future performance.
Inspire (INSP) has a consensus price target suggesting a 25.9% upside. Upward revisions in earnings estimates may indicate potential near-term stock gains.
A 25.9% upside potential suggests significant room for growth in Inspire (INSP), while positive earnings estimate revisions indicate potential short-term gains, influencing investor sentiment.
Inspire Medical's Earnings Surge in Q4
1 month agoInspire Medical Systems (INSP) reported Q4 earnings per share of $1.15, surpassing the $0.73 consensus estimate, highlighting strong financial performance.
Inspire Medical's strong EPS of $1.15 versus the $0.73 estimate indicates robust financial performance, likely boosting investor confidence and potentially increasing stock value.
Frequently Asked Questions About INSP Stock
What is Inspire Medical Systems, Inc.'s (INSP) stock forecast for 2025?
Based on our analysis of 17 Wall Street analysts, Inspire Medical Systems, Inc. (INSP) has a median price target of $234.00. The highest price target is $270.00 and the lowest is $190.00.
Is INSP stock a good investment in 2025?
According to current analyst ratings, INSP has 12 Buy ratings, 5 Hold ratings, and 0 Sell ratings. The stock is currently trading at $162.16. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for INSP stock?
Wall Street analysts predict INSP stock could reach $234.00 in the next 12 months. This represents a 44.3% increase from the current price of $162.16. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Inspire Medical Systems, Inc.'s business model?
Inspire Medical Systems generates revenue by developing and commercializing its Inspire therapy device, an implantable neurostimulation solution for obstructive sleep apnea patients who cannot use CPAP machines. The company collaborates with hospitals and medical professionals to integrate its technology into sleep health management, which helps expand its market reach.
What is the highest forecasted price for INSP Inspire Medical Systems, Inc.?
The highest price target for INSP is $270.00 from at , which represents a 66.5% increase from the current price of $162.16.
What is the lowest forecasted price for INSP Inspire Medical Systems, Inc.?
The lowest price target for INSP is $190.00 from Jonathan Block at Stifel, which represents a 17.2% increase from the current price of $162.16.
What is the overall INSP consensus from analysts for Inspire Medical Systems, Inc.?
The overall analyst consensus for INSP is bullish. Out of 17 Wall Street analysts, 12 rate it as Buy, 5 as Hold, and 0 as Sell, with a median price target of $234.00.
How accurate are INSP stock price projections?
Stock price projections, including those for Inspire Medical Systems, Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
